Cargando…

The consideration of surgery on primary lesion of advanced non-small cell lung cancer

BACKGROUND: Numerous reports have shown that medical treatment confers excellent survival benefits to patients with advanced stage IV non-small cell lung cancer (NSCLC). However, the implications of surgery for primary lesions as palliative treatment remain inconclusive. METHODS: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jianghao, Ren, Jiangbin, Wang, Kan, Tan, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103432/ https://www.ncbi.nlm.nih.gov/pubmed/37060050 http://dx.doi.org/10.1186/s12890-023-02411-w

Ejemplares similares

The outcomes of margin status after sleeve lobectomy for patients of non–small cell lung cancer
por: Ren, Jianghao, et al.
Publicado: (2022)

Reconstruction of the trachea and carina: Surgical reconstruction, autologous tissue transplantation, allograft transplantation, and bioengineering
por: Ren, Jianghao, et al.
Publicado: (2022)

shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8
por: Liu, Ruijun, et al.
Publicado: (2022)

Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
por: Liang, Jun-Li, et al.
Publicado: (2014)

Mucosa‑associated lymphoid tissue in the central nervous system presenting as meningioma: A case report
por: Ren, Jiangbin, et al.
Publicado: (2023)

Analysis for discharge within 2 days after thoracoscopic anatomic lung cancer surgery
por: Xu, Yuanyuan, et al.
Publicado: (2023)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

The significance of systematic lymph node dissection in surgery for early-stage non-small cell lung cancer patients aged ≤40 years
por: Guo, Zhi-Yi, et al.
Publicado: (2021)

Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
por: Dalurzo, Mercedes L, et al.
Publicado: (2021)

The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer
por: Tateishi, Akiko, et al.
Publicado: (2020)

Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer
por: Ren, Xiao-Cang, et al.
Publicado: (2019)

PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
por: Ren, Zhixuan, et al.
Publicado: (2023)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
por: Ren, Sijia, et al.
Publicado: (2021)

Immunomodulatory effects of intestinal lung axis microecology and other factors on the prognosis of advanced non-small cell lung cancer
por: Shen, Changxing, et al.
Publicado: (2019)

Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non‐small‐cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2022)

Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
por: Zhong, Yuejiao, et al.
Publicado: (2020)

Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
por: Hao, Zhexue, et al.
Publicado: (2021)

Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy
por: Li, Kuo, et al.
Publicado: (2021)

Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
por: Nawashiro, Ayako, et al.
Publicado: (2022)

Minimal invasive surgery in locally advanced N2 non-small cell lung cancer
por: Patané, Ana Karina
Publicado: (2021)

Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
por: Lu, Ying-Qiang, et al.
Publicado: (2017)

Prognosis Model of Advanced Non-Small-Cell Lung Cancer Based on Max-Min Hill-Climbing Algorithm
por: Fu, Weizheng, et al.
Publicado: (2022)

Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers
por: Zhang, Xiang-Yan, et al.
Publicado: (2020)

Increased Incidence of Thrombotic Complications With Non-small Cell Lung Cancer Necessitates Consideration of Prophylactic Anticoagulation in Young Individuals
por: Bagchi, Arindam, et al.
Publicado: (2021)

Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer
por: Ren, Hui, et al.
Publicado: (2019)

Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
por: Wang, Chin-Chou, et al.
Publicado: (2017)

Recent advances in the treatment of non-small cell and small cell lung cancer
por: Stinchcombe, Thomas E.
Publicado: (2014)

Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team
por: Al Zaidi, Muteb, et al.
Publicado: (2020)

Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery
por: Wang, Hui, et al.
Publicado: (2023)

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
por: Takigawa, N, et al.
Publicado: (2006)

The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
por: Ren, Jiangbin, et al.
Publicado: (2023)

Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases
por: Qiao, Meng, et al.
Publicado: (2021)

Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review
por: Sherwood, James, et al.
Publicado: (2015)

Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Wang, Chengdi, et al.
Publicado: (2019)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Recent advances in the management of non-small cell lung cancer
por: Shojaee, Samira, et al.
Publicado: (2017)

Targeted therapies for advanced non-small cell lung cancer
por: Ai, Xiaojuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mms11f9il3neuf4ulb5kl8caej